Overall, we found that at metastatic sites the uptake of labeled transferrin may be variable, and that high physiological expression of TfR and TfR2 by target organs can affect the ability of Tf-conjugates to identify tumor sites, particularly for smaller lesions. Here, TFRC is linked to neoplasm.